Progress in the treatment of osteosarcoma.
D000293:Adolescent; D000328:Adult; D000671:Amputation, Surgical; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000473:pathology / Q000628:therapy*; D002455:Cell Division; D002648:Child; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D012516:Osteosarcoma / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D011882:Radiotherapy, High-Energy; D013997:Time Factors
D000970:Antineoplastic Agents; D004317:Doxorubicin; D002955:Leucovorin; D008727:Methotrexate